28TH AUSTRALASIAN SOCIETY OF CLINICAL IMMUNOLOGY & ALLERGY (ASCIA) ANNUAL CONFERENCE
ANZ Viaduct Events CentreAuckland, NEW ZEALAND Visit the Venue to read more
Preparations are now well underway for the ASCIA 2017 conference to be held in Auckland, New Zealand from 13-15 September 2017 at the Viaduct Events Centre.
The conference will include presentations from the following confirmed international speakers:
Professor Carsten Bindslev-Jensen (ASCIA keynote speaker)
Dr Lene Heise Garvey (ASCIA-ANZAAG Drug Allergy Symposium keynote speaker)
Professor Jonathan Hourihane (CFAR Symposium and ASCIA keynote speaker)
Prof Nikos Papadopoulos (CFAR Symposium and ASCIA keynote speaker)
Professor Werner Pichler (ASCIA-ANZAAG Drug Allergy Symposium keynote speaker)
Professor Jennifer Puck (ASCIA keynote speaker)
Professor Hugh Sampson (CFAR Symposium and ASCIA keynote speaker)
Professor Scott Sicherer (CFAR Symposium and ASCIA keynote speaker)
There will also be more than 40 speakers and chairs from New Zealand and Australia participating in this conference and we expect more than 400 delegates.
On Friday 15 September the ASCIA 2017 conference will include the following concurrent sessions:
ASCIA 2017 Drug Allergy Symposium held in conjunction with the Australian and New Zealand Anaesthetic Allergy Group (ANZAAG) on Friday afternoon, followed by the ANZAAG annual meeting on Saturday 16 September.
ASCIA 2017 Nurse and Dietitian Updates (all day).
ASCIA 2017 will be also be held in conjunction with:
Centre for Food and Allergy Research (CFAR) Symposium 2017 on Tuesday 12 September.
Food Allergy introductory course for Dietitians on Saturday 16 September.
ASCIA annual conferences continue to provide an international standard of continuing professional development in the areas of allergy and clinical immunology. They are also an opportunity to interact with colleagues working in these areas.
For information on what to see and do in New Zealand (pre or post conference) visit www.newzealand.com/au/
We look forward to welcoming you to Auckland in September.
Dr Maia Brewerton, Dr Anthony Jordan
ASCIA 2017 Co-ChairsDr William Smith
ASCIA PresidentJill Smith
Professor Carsten Bindslev-Jensen PhD DMSci
Professor in Allergology at University of Southern Denmark, chair of Odense Research Center for Anaphylaxis, and chair of the Department of Dermatology and Allergy Center in Odense, Denmark.
Professor Carsten Bindslev-Jensen graduated from the University of Copenhagen. He obtained his PhD in 1985 and his DMSci in 1988. He is author of more than 250 papers in international journals. His scientific fields of interest include food allergy, drug allergy and anaphylaxis in children and adults. He has been chair of the Danish Society for Allergology and is currently chair of Dermatology Section of the European Academy for Allergy and Clinical Immunology. Professor Bindsley-Jenson is a fellow of AAAAI.
Professor Lene Heise Garvey MB CHB PhD
Co-founder and chief physician of the Danish Anaesthesia Allergy Centre, Denmark
Professor Lene Heise Garvey graduated in Medicine from the University of Bristol in 1994 and specialized in Anaesthesiology in Denmark in 2006. She defended her PhD on “Allergic reactions during anaesthesia and surgery” in 2010 and has since achieved a subspecialization in Allergology. She is co-founder and chief physician of the Danish Anaesthesia Allergy Centre, the National Reference Centre for investigation of perioperative hypersensitivity in Denmark, established in 1999.
Professor Garvey is a consultant in the Allergy Clinic, Herlev and Gentofte Hospitals, Denmark and shares her time between a half-time post-doc research position and seeing patients in both anaesthesia allergy and general allergy clinics. She is an active member of several task forces in the Drug Allergy Interest Group in EAACI and is currently heading a task force on perioperative hypersensitivity. Her research interests include all aspects of perioperative hypersensitivity, treatment and mechanisms of anaphylaxis, allergy to chlorhexidine and other rare allergens.
Professor Jonathan Hourihane MB BCh BAO DM
Professor of Paediatrics and Child Health in University College Cork (UCC), Ireland
Professor Jonathan Hourihane graduated from Trinity College Dublin in 1987 and undertook his higher training in Southampton and London, UK. His primary area of clinical and research interest is in paediatric food allergy and anaphylaxis. He has been Professor of Paediatrics and Child Health in University College Cork, Ireland, since 2005.
Professor Hourihane is President of the Irish Association of Allergy and Immunology, co-Principal Investigator of the BASELINE, Ireland’s only birth cohort study (www.baselinestudy.net.) and the INFANT Research Centre in UCC (www.infantcentre.ie ). He is a founding board member of the Clemens von Pirquet Foundation and the Irish Food Allergy Network (www.ifan.ie) and sits on the Board, the Scientific Committee and the Strategy Committee of the National Children’s Research Centre, Dublin.
Professor Nikos Papadopoulos MD PhD
Professor of Allergy and Paediatric Allergy at the University of Manchester, UK, Professor of Allergy and Paediatric Allergy, Head of the Allergy Department, 2nd Pediatric Clinic, University of Athens (NKUA), Greece
Professor Nikos Papadopoulos graduated from Medical School at the National and Kapodistrian University of Athens (NKUA) and received his doctorate from the Center of Immunology of Infectious Disease-AIDS, Chair of Microbiology, Medical School, NKUA. He was a Postdoctoral research fellow at the Immunology Laboratory, Hellenic Anticancer Institute, “Agios Savas” Hospital.
His main research focus is the role of infections in asthma and he has active research programs in food allergy. He has extensive collaborations and leading roles in EU projects such as EARIP, iFAAM, FAST and PreDicta. Professor Papdopoulos has published more than 250 papers, has received several international awards, and is invited to speak at international scientific meetings some 30 times a year. He has served in committees of EAACI, GA2LEN, WAO, EFA and ARIA. He was the 2013-2015 President of EAACI.
Professor Werner Joseph Pichler MD
Scientific Director of ADR-AC GmbH (Adverse Drug Reaction Analysis & Consulting), Bern, Switzerland
Professor Werner Joseph Pichler studied medicine at the University of Innsbruck, Austria and trained as an immunologist in Vienna and at the National Institutes of Health (NIH), Bethesda, USA. He became an internist and clinical immunologist by training in the Division of Clinical Immunology at the Medical School Hannover, Germany. From 1984 he worked at the University of Bern, Switzerland. He became Head of Division of Allergology and Professor for Clinical Immunology, Department of Rheumatology, Clinical Immunology & Allergology, University of Bern, retiring in 2014. He was President of the Swiss Society of Allergy and Immunology 1993-94 and in 2004 founded the biennial drug hypersensitivity meeting (DHM), now the biggest meeting worldwide on drug hypersensitivity.
Professor Pichler focused his research on drug hypersensitivity and has co-authored over 200 publications. He recently edited the book Drug Hypersensitivity and is editor of two other books on the subject. In 2006 he co-founded ADR-AC GmbH (Adverse Drug Reaction Analysis & Consulting) a company devoted to research, diagnosis and consulting on drug hypersensitivity. In 2010 he was visiting professor at the University of Adelaide and in 2015-2016 spent three months as visiting professor at Mahidol University, Bangkok.
Professor Jennifer Puck MD
Professor of Pediatrics University of California San Francisco (UCSF), USA
Earning her undergraduate and medical degrees at Harvard University and Harvard Medical School, Professor Jennifer Puck completed clinical and research training in pediatrics, infectious diseases and immunology at Washington University in St. Louis, Missouri, and Baylor College of Medicine in Houston, Texas. She joined UCSF in 2006 after serving on the faculties of the University of Pennsylvania in Philadelphia and the National Human Genome Research Institute, NIH, in Bethesda, Maryland. In addition to caring for patients as an immunologist and teaching biomedical trainees, she has a basic and translational research program that focuses on human immune disorders as well as mouse models of lymphocyte development. She has published over 185 peer reviewed research papers in addition to over 100 chapters and reviews; she is co-editor of Primary Immunodeficiencies: A Molecular and Genetic Approach, published in its 3rd edition in 2014.
Professor Puck conceived and developed a newborn screening test to detect SCID that is now widely adopted in newborn screening panels in the US and a growing number of countries. This allows infants affected with SCID and other conditions with insufficient T cells to be detected early and treated.
Professor Puck directs the UCSF Jeffrey Modell Diagnostic Center for Primary Immunodeficiencies. She serves on the Medical Advisory Committee of the Immune Deficiency Foundation, the Committee on Primary Immunodeficiency Disease of the International Union of Immunological Societies, the Board of Scientific Councilors of NIAID, and the Steering Committees of the Primary Immune Deficiency Treatment Consortium (PIDTC) as well as the US Immunodeficiency Network (USIDNET). She has been elected to the American Society of Clinical Investigation (ASCI), Society for Pediatric Research (SPR), Association of American Physicians (AAP), American Pediatric Society (APS) and National Academy of Medicine. She received the Abbot Award in Clinical and Diagnostic Immunology from the American Society of Microbiology in 2013 and the Colonel Harlan Sanders Award for Lifetime Achievement in Genetics from the March of Dimes in 2014.
Professor Hugh A. Sampson MD
Kurt Hirschhorn Professor of Pediatrics and Director of the Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai, New York, USA
Professor Hugh Sampson has nearly 35 years’ experience in translational research focusing on food allergic disorders and basic immunologic mechanisms responsible for these disorders. He received his medical degree from the State University of New York at Buffalo School of Medicine. This was followed by a residency in Pediatrics at the Children’s Memorial Hospital and a fellowship in Allergy and Immunology at Duke University Hospital.
Professor Sampson’s research has been funded continuously by a number of grants from the National Institutes of Health (NIH) including being the Principal Investigator for the Consortium for Food Allergy Research. He was elected to membership in the Institute of Medicine of the National Academies in 2003 for his research accomplishments.
Professor Sampson has published over 450 articles, 88 book chapters and co-edited 7 books, primarily on clinical and immunopathogenic aspects of food allergic disorders. He is past chair of the Section on Allergy and Immunology of the American Academy of Pediatrics and the past-president of the American Academy of Allergy, Asthma and Immunology. His presidential initiative during his tenure led to the NIAID Guidelines on the Diagnosis and Management of Food Allergy. He has served on the Editorial Board of 5 allergy journals, including 20 years on the JACI Editorial Board. In November 2015 he stepped down as Dean for Translational Biomedical Sciences at Mount Sinai to devote 40% of his time to DBV Technologies as their Chief Scientific Officer.
Professor Scott Sicherer MD
Elliot and Roslyn Jaffe Professor of Allergy, Immunology and Pediatrics and Chief of the Division of Pediatric Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York, USA
Professor Scott Sicherer’s food allergy research, funded by the National Institutes of Allergy and Infectious Diseases and Food Allergy Research and Education, include studies on: natural history, epidemiology, psychosocial issues, modalities to educate physicians and parents, genetics and treatment modalities. He has published over 200 articles in scientific journals, and has authored over 50 book chapters.
He is past chair of the Adverse Reactions to Foods Committee of the Academy of Allergy, Asthma, and Immunology, of the Section on Allergy and Immunology of the American Academy of Pediatrics, and of the American Board of Allergy and Immunology. He is associate editor of the Journal of Allergy and Clinical Immunology, In Practice. He has authored four food allergy books for the lay public. Professor Sicherer has been recognized by Thompson Reuters for being among the top 1% of researchers for most cited documents in their specific field.
ASCIA 2017 Conference delegates can register online (available until 8 September 2017) and a Tax Invoice (receipt) will be sent after payment has been processed.
Please direct all registration enquiries to:
ASCIA 2017 Conference Secretariat
PO Box 5005
South Melbourne VIC 3205
Telephone: +61 3 9682 0500
Facsimile: +61 3 9682 0344
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Sofitel Auckland Viaduct Harbour
Location: 21 Viaduct Harbour Avenue, Auckland
Phone: +64 9 909 9000
Booking: By Phone, and quote “ASCIA 2017” Conference
By Email: H8577@sofitel.com and quoting “ASCIA 2017” Conference
Online: www.sofitel.com and enter the Preference Code “BGRE”
Superior Room $315
Located on the water edge with floor to ceiling windows & private balconies, spacious bedrooms & suites offer views over the Viaduct basin & Auckland city. Features include espresso machines, Bose sound systems, French amenities & oversized bathrooms
Lounge in the sprawling space of Sofitel Auckland on Viaduct Habour’s suites. Each suite offers guests serene Auckland luxury accommodation, with inspiring views, an oversized bathroom, LCD television, Bose sound system and cloudlike Sofitel MyBed.
Sofitel Auckland Viaduct Harbour is a short 10 minute walk from the Viaduct Events Centre.
The Sebel Auckland Viaduct Harbour
Location: 85 Customs Street West, Auckland
Phone: +64 (9) 9784 000
Room: City View Studio Suite
Booking: Reservations made via accorhotels.com and type in the hotel name (Sebel Auckland Viaduct Harbour), dates between/ including 12-16 Sep, and use the preference code BGPG.
City View Studio Suite $295
A spacious open plan room with modern furnishings, a fully equipped kitchenette featuring microwave, hob and dishwasher and well appointed bathroom.
Located at the waters edge in the Viaduct Harbour and adjacent to Auckland’s central business district, the property provides extensive views of the marina and the city. The finest bars and restaurants, cafés, shops, transportation hubs and numerous leisure activities are all on your doorstep. An ideal haven from which to explore all that this fantastic city has to offer. Features stylish Apartments and Suites.
The Sebel Auckland Viaduct Harbour is a short 8 minutes walk to the Viaduct Events Centre.
The Sebel Quay West Auckland
Location: 8 Albert Street, Auckland
Phone: +64 (9) 3096 000
Room: Two Bedroom Apartment
Booking: Reservations made via accorhotels.com and type in the hotel name (Sebel Quay West Auckland), dates between/ including 12-16 Sep.
Two bedroom Apartments are available at The Sebel Quay West Auckland. Due to the Sebel Quay West Auckland having only a small number of two bedroom apartments, the rate is only available upon request and no set rate is negotiated with the property.
ASCIA 2017 posters (displayed from Wednesday 13 to Friday 15 September 2017)
ASCIA 2017 clinical grand rounds oral presentations (for advanced trainees only)
Abstracts must be submitted online by the closing date of Friday 14 July 2017. Acceptance of abstracts will be confirmed in August and they will be published online in the Internal Medicine Journal (IMJ) in September 2017.
Abstract submission deadline 2017-07-14
Only abstracts submitted in English will be reviewed.
Abstracts should be original work, not previously presented at an international meeting.
Abstracts should be around 250 words (but no longer than 300 words) and submitted in Microsoft Word format only, using the template provided on this web page.
Abstract titles (in capitals) should be short and descriptive, with no abbreviations.
Abstracts may contain tables, pictures, diagrams.
Abstracts should NOT contain symbols such as Greek letters nor arrows.
All abbreviations must be spelled out on first use.
Abstracts should be thoroughly checked for spelling and grammar.
Abstracts should contain the following headings: background, method, results and conclusion.
Abstracts must be submitted by 5pm on Friday 14 July 2017 for consideration by the program committee. Authors will be notified of acceptance of abstracts by early August 2017.
To be accepted, abstract authors must be registered for the Conference, by the early bird registration deadline of 5pm on Friday 14 July 2017.
ASCIA 2017 Awards and Travel Grants
A limited number of travel grants are awarded (during the conference) to delegates (advanced trainees, dietitians, nurses, students) who reside outside of the region and have submitted an abstract for a poster and/or clinical grand round presentation.
Awards of $1,000 each for selected posters and clinical grand round presentations will be presented at the end of the conference. After the conference these are listed on the ASCIA website:
Terms and Conditions
Submission of an abstract and ticking of the box in the abstract submission form indicates an understanding of the following rules for participation in ASCIA 2016:
All author(s) approve submitting this work for presentation.
The author(s) transfer(s) all copyright ownership of the named abstract to ASCIA 2017
The Author(s) agree(s) to materially confine their presentations to information in the abstract if accepted for presentation; if an author has more than one abstract accepted each presentation will be materially confined to the information in the abstract selected for the specific session.
At least one author will be available to present the abstract if selected for the program. The authors will immediately notify the ASCIA 2017 Secretariat if they are unable to present an abstract or if the presenting author is changed.
Abstracts will only be accepted if the author has registered for the ASCIA 2017 Conference.
Poster presentations will be held on Wednesday 13, Thursday 14 and Friday 15 September and presenters of selected posters will be advised in August.
Clinical Grand Rounds oral presentations will be held on Friday 15 September immediately following morning tea.
Posters should be on flexible lightweight paper, cloth or board, no larger than A0 (841mmx1189mm), portrait orientation and include the purpose of the study, a brief statement of methods, summary of results and conclusion.
Abstracts will not be selected without results being included.
Standard abbreviations may be used but Greek symbols and arrows should not be included.
All enquiries regarding abstracts for ASCIA 2017 should be emailed to email@example.com
Suite 238, 117 Old Pittwater Road, Brookvale, NSW 2100, Australia
PO Box 450 Balgowlah NSW 2093, Australia